Company intelligence / Profile preview

Sonova

Ownership: Public · SOON
Employees: ~18554
Development stage: Commercial

Overview

Sonova provides a comprehensive portfolio of commercialized hearing care solutions including advanced hearing aids and cochlear implants. The company’s products are widely used globally and have demonstrated significant improvements in quality of life for people with hearing loss[1][2][5].

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Partnerships

Sennheiser Consumer Division licensing agreement for consumer audio products

Financials

Market cap: $140.9B
Total revenue: $13T

Beyond the preview

Go deeper on Sonova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonova.

Explore the full profile